title: [Fragile X, fulminant hepatitis: new hope].
authors.affiliation: jeanyves.nau@gmail.com
authors.forename: Jean-Yves
authors.initials: JY
authors.lastname: Nau
mesh_terms: D000818:Animals; D000951:Antigens, Neoplasm / Q000008:administration & dosage*; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy; D014408:Biomarkers, Tumor / Q000008:administration & dosage*; D035843:Biomedical Research / Q000639:trends; D003072:Cognition Disorders / Q000188:drug therapy; D051860:Fragile X Messenger Ribonucleoprotein 1 / Q000008:administration & dosage* / Q000235:genetics; D005600:Fragile X Syndrome / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics; D006505:Hepatitis / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D037181:Lectins, C-Type / Q000008:administration & dosage*; D017114:Liver Failure, Acute / Q000188:drug therapy* / Q000209:etiology; D000073718:Pancreatitis-Associated Proteins; D064529:Receptor, Metabotropic Glutamate 5; D018094:Receptors, Metabotropic Glutamate / Q000037:antagonists & inhibitors*
chemical_list: D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D051860:Fragile X Messenger Ribonucleoprotein 1; D037181:Lectins, C-Type; D000073718:Pancreatitis-Associated Proteins; D064529:Receptor, Metabotropic Glutamate 5; D018094:Receptors, Metabotropic Glutamate; C497683:FMR1 protein, human; C000612141:REG3A protein, human